Nanomaterials for the Management of Infectious Diseases

Infectious diseases have been a major threat to the global healthcare sector, presenting challenges in their management. Modulating immune responses to pathogens remains the backbone of the fight against the infectious agents. This new volume, Nanomaterials for the Management of Infectious Diseases, investigates how engineered nanoparticles, with their distinct properties, make them suitable candidates in the field of biomedical research for fighting against infectious diseases. Keeping these facts in mind and expanding the knowledge about nanotechnological application in healthcare sector and its role in disease management, this book has been organized into two sections. It begins with the application of nanoparticles as innovative tools in disease diagnosis, preventing host invasion, and discusses recent innovations in nanomedicine for improving disease pathology, which will eventually help in designing strategies for immunomodulation as well as for disease management, which is covered in the second section. The book discusses engineered nanoparticles and their role in disease diagnostics, preventing host invasion, and recent innovations in nanomedicine. It explores nanoparticle technologies in infectious disease management, immunomodulatory immunostimulatory nanoparticles (innate and adaptive immune stimulatory), ligands for cell and/or tissue specific drug delivery, and NP pharmacokinetics, pharmacodynamics, and their role as a barrier to prevent host invasion, and more. Also discussed are engineered nanoparticles and their use in immunomodulation and disease management, looking at nanobiotics and microbicides as innovative alternatives for combating antibiotic resistance and modulating immune responses, immunodefense against intracellular infections, antiparasitic effects of metallic nanoparticles, nanoparticles as vaccine stabilizers, nanomaterials in wound healing and more. Overall, the book provides a thorough overview of engineered nanoparticles and how they can provide safer and effective therapeutic and prophylactic option for the prevention and management of infectious diseases.